Seyithan TAYSI | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Seyithan TAYSI | Molecular Biology | Best Researcher Award 

Professor | Gaziantep University | Turkey

Prof. Dr. Seyithan Taysi is a distinguished Professor of Medical Biochemistry at Gaziantep University, widely recognized for his pioneering work on oxidative stress, antioxidant mechanisms, free radicals, and molecular oncology. He earned his Ph.D. in Medical Biochemistry from Atatürk University, where his research on oxidative mechanisms and cellular stress regulation received the Jury’s Special Award for Best Article. Currently, he leads advanced biochemical research and teaching programs, having completed over ninety-five funded projects and holding six patents. His editorial service includes roles on international journal boards such as BioMed Research International and the International Journal of Clinical and Experimental Ophthalmology, where he has reviewed more than four hundred manuscripts. Prof. Taysi’s research focuses on oxidative and nitrosative stress, the Nrf2/Keap1 pathway, and antioxidant-based therapies, integrating biochemical and molecular approaches to improve cancer treatment and radioprotection. He has 162 documents cited by 3,969 documents, with 5,099 citations and an h-index of 39, reflecting his global influence and impact in biomedical research.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Taysi, S., et al. Oxidative stress modulation in cancer therapy. Free Radical Biology & Medicine. Cited by 45 articles.

Taysi, S., et al. Phytotherapeutic agents against radiation-induced cellular damage. Antioxidants (Basel). Cited by 38 articles.

Taysi, S., et al. Nrf2/Keap1 pathway as a therapeutic target in oxidative diseases. Frontiers in Molecular Biosciences. Cited by 62 articles.

Taysi, S., et al. Role of antioxidants in radiotherapy protection. BioMed Research International. Cited by 55 articles.

Taysi, S., et al. Oxidative stress biomarkers in cancer patients. Clinical Biochemistry. Cited by 97 articles.

Nahla Hemdan | Systems Biology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Nahla Hemdan | Systems Biology | Best Researcher Award 

Associate professor | National Research Centre | Egypt

Dr. Nahla Abdel-Fattah Hemdan Mohamed is an accomplished Egyptian researcher specializing in soil and water use, sustainable agriculture, and environmental protection. With over two decades of academic and research experience, she has significantly contributed to advancing irrigation technologies, soil fertility management, and strategies for combating desertification. Currently serving as a Researcher at the National Research Centre (NRC), Cairo, Dr. Hemdan has participated in numerous national and international projects focusing on climate change adaptation, water efficiency, and soil amendments. Her scientific career demonstrates a strong integration of applied research and practical solutions to pressing agricultural challenges in arid regions. She has published extensively in reputed international journals, delivered keynote presentations at international conferences, and played an active role in scientific societies worldwide. With her patents, academic achievements, and leadership in sustainable agriculture, Dr. Hemdan is widely recognized as a leading scientist dedicated to improving food security and environmental sustainability.

Professional Profile

Scopus

ORCID

Google Scholar

Education

Dr. Hemdan pursued her higher education with a deep focus on soil sciences, irrigation management, and ecological resource utilization. She earned her Ph.D. in Irrigation Systems and Drip Irrigation Technology from the Humboldt University of Berlin, Germany, with a dissertation on advanced irrigation systems and management experiments in Egypt. Her doctoral research contributed valuable knowledge on sustainable water use in agriculture. Earlier, she obtained her M.Sc. in Soil Sciences from Assiut University, where she studied water regimes of crops under drip irrigation at the El-Kharga Oasis. This work provided insights into optimizing crop performance under desert conditions. Dr. Hemdan’s strong academic foundation bridges Egyptian agricultural challenges with international research excellence. Her multidisciplinary expertise combines soil chemistry, water management, and environmental sustainability, making her educational journey a cornerstone for her impactful research career.

Experience

With an extensive professional background, Dr. Hemdan has established herself as a leader in soil and water research. At the National Research Centre (NRC), Cairo, she has spearheaded multiple projects addressing drought tolerance, saline water management, and organic fertilizers. Her work spans applied research, patent development, project management, and event organization for advancing agricultural innovation. She has also served as a scientific reviewer for prestigious journals such as the Journal of Environmental Management. Internationally, Dr. Hemdan has represented Egypt in training programs and internships on desertification control, climate change, and sustainable resource management in China and India. She has been a pivotal member of national projects funded by NRC, focusing on maximizing water efficiency and adapting agriculture to climate change. Her extensive conference participation across Europe, Africa, and Asia reflects her global academic engagement and her role as a strong voice in sustainable agriculture.

Research Interests

Dr. Hemdan’s research centers on soil fertility, irrigation efficiency, and climate-smart agriculture. She is particularly interested in the application of biochar, compost, vermicompost, and nano-fertilizers for improving soil properties and enhancing crop resilience under stress conditions. Her work on saline water management and soil reclamation technologies addresses critical issues in arid and semi-arid ecosystems. Additionally, she focuses on drip irrigation innovations, eco-friendly soil amendments, and sustainable practices to mitigate desertification. Her projects align with the United Nations Sustainable Development Goals (SDGs), especially those targeting food security, climate action, and land restoration. She actively collaborates with multidisciplinary teams to evaluate advanced agricultural models such as AquaCrop for yield prediction under climate stress. Driven by the urgency of water scarcity and environmental degradation, Dr. Hemdan’s research integrates practical solutions with scientific innovation, making her contributions vital to agricultural sustainability in Egypt and globally.

Awards

Dr. Hemdan has been recognized for her pioneering work in sustainable agriculture and soil management. She has secured patents from the Academy of Scientific Research & Technology (ASRT), Egypt, covering innovations such as safe integral biocompost, sulphur integral compost, potassium-enriched compost, phosphate-enriched compost, and composted moringa seed cake. These patents highlight her role in translating scientific research into practical technologies for farmers. Beyond patents, she has earned international internships and training awards, including programs in China and India on desertification control and climate change. Her contributions have been acknowledged by the Egyptian Soil Science Society (ESSS) through conference platforms, where she has consistently presented her findings. Furthermore, her memberships in leading scientific organizations, such as the Soil Science Society of America and the American Society of Agronomy, reflect her esteemed standing in the global research community.

Top Noted Publications

Dr. Hemdan has an impressive publication record across high-impact journals, emphasizing soil amendments, irrigation, and sustainable agriculture. Selected works include:

Using moringa oleifera seed cake and compost as organic soil amendments for sustainable agriculture in Valencia orange orchard
Journal: Future of Food: Journal on Food, Agriculture & Society
Citations: Cited by over 25 articles

Reclamation and Improvement of Saline Soils Using Organo–Mineral–Natural Resources, Treated Saline Water, and Drip Irrigation Technology
Journal: Water
Citations: Cited by over 5 articles

Impact of Biochar Mixed with Compost on Olive and Some Soil Properties under Saline Water and Soil Management
Journal: International Journal of Mechanical Engineering
Citations: Cited by over 10 articles

Utilization of Biochar with Soil Amendments and AquaCrop model under Saline Water and Soil Management at Ismailia Desert, Egypt
Journal: International Journal of Mechanical Engineering
Citations: Cited by over 12 articles

Effect of Soil Amendments and Water Requirements on Flax Yield and Fertilizer Efficiency
Journal: American-Eurasian Journal of Agronomy
Citations: Cited by over 20 articles

Effect of Vermicompost and NPK-Nano Fertilizer on Jojoba Plant under Degraded Soil Condition
Journal: Current Science International
Citations: Cited by over 15 articles

Conventional and Nano Fertilizers and Its Effect on Growth and Nutrient Status of Lupine Plants
Journal: Current Science International
Citations: Cited by over 18 articles

Effect of Organic Fertilization with Moringa Oleifera Seeds Cake and Compost on Storability of Valencia Orange Fruits
Journal: Egyptian Journal of Chemistry
Citations: Cited by over 8 articles

Mycorrhizal Fungi and Rock Phosphate Application to Mitigate Soil Salt Stress
Journal: Middle East Journal of Agriculture Research
Citations: Cited by over 6 articles

Conclusion

Dr. Nahla Abdel-Fattah Hemdan Mohamed is highly suitable for the Best Researcher Award. Her outstanding academic background, impactful publications, patents, and strong record of applied research in sustainable agriculture make her a strong candidate. She combines scientific innovation with practical solutions to global challenges such as desertification, water scarcity, and soil salinity. While expanding her international footprint and publishing in top-tier journals could further elevate her profile, her achievements already demonstrate excellence in research, innovation, and contribution to society. Overall, she is a deserving nominee whose work significantly advances the field of agricultural sustainability.

Camille EVRARD | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Camille EVRARD | Molecular Biology | Best Researcher Award 

MD-PhD, at Poitiers University Hospital, France.

Dr. Camille Evrard is a University Lecturer and Hospital Practitioner (MD-PhD) specializing in medical oncology at the Pôle Régional de Cancérologie, Poitiers University Hospital, France. With a strong background in clinical and research oncology, she has focused on circulating tumor DNA (ctDNA) in pancreatic and solid tumors. Dr. Evrard has contributed extensively to cancer research, emphasizing precision medicine and innovative therapeutic strategies. She is actively engaged in academia and clinical practice, ensuring a holistic approach to oncology care and education. Her international collaborations, including work at Karolinska Institutet, further solidify her role as a leader in oncology research.

Professional Profile

Scopus

Google Scholar

Education 🎓

Dr. Evrard’s academic journey began with a High School Diploma in Science, followed by medical studies at the University of Reims. She ranked nationally in the competitive medical exam and pursued specialization in medical oncology at Poitiers University Hospital. She obtained multiple advanced degrees, including a University Degree in Clinical Carcinology (Institut Gustave Roussy), a Master’s in Biology Health, and a PhD in Science focusing on ctDNA in solid tumors. Her research has been instrumental in understanding prognostic biomarkers in pancreatic cancer. Additionally, she completed diplomas in medical pedagogy, head and neck cancer, and health statistical methods, showcasing her commitment to continuous learning and expertise expansion.

Experience 💼

Dr. Evrard’s extensive medical career includes an externship at Reims University Hospital, followed by an internship in medical oncology across various hospitals in France. She progressed to a Head of Clinic Assistant role at Poitiers University Hospital and later became a Contractual Hospital Practitioner. In 2023, she secured a prestigious position as a University Lecturer and Hospital Practitioner. Her diverse clinical roles have provided her with comprehensive expertise in cancer treatment, patient management, and medical education. Additionally, her tenure in cancer biology and radiotherapy has strengthened her multidisciplinary approach to oncology.

Research Interests 🌍

Dr. Evrard’s research focuses on the role of circulating tumor DNA in cancer prognosis and treatment response. Her investigations into KRAS-mutated ctDNA in pancreatic cancer have provided valuable insights into early diagnosis and precision therapy. She also explores statistical modeling in oncology, integrating health data analysis to optimize patient outcomes. Her work at the PaCaRes laboratory at Karolinska Institutet further extends her research on pancreatic cancer biomarkers. Through her dedication to translational research, she aims to bridge the gap between laboratory discoveries and clinical applications, improving personalized medicine approaches.

Awards 🏆

Dr. Evrard has received numerous accolades for her contributions to oncology research and medical education. Her PhD work on ctDNA has been recognized for its innovative approach to cancer biomarkers. She has been honored for her excellence in clinical research and has secured competitive academic mobility grants, including her placement at Karolinska Institutet. Additionally, her participation in international medical conferences has earned her awards for outstanding presentations and contributions to cancer research advancements.

Top Noted Publications 📘

The series of studies led by C. Evrard and colleagues have significantly advanced our understanding of the role of circulating tumor DNA (ctDNA) in pancreatic cancer, particularly regarding its prognostic and predictive value. Below is a summary of each study:

  1. “Predictive and Prognostic Value of Circulating Tumor DNA in Unresectable Pancreatic Cancer” (Journal of Clinical Oncology, 2022):

    • Objective: To evaluate the association between ctDNA levels and patient outcomes in unresectable pancreatic adenocarcinoma (UPA).
    • Methods: Blood samples were collected from 65 patients before chemotherapy initiation and at day 28. ctDNA was analyzed using digital droplet PCR to detect KRAS mutations.
    • Findings: High levels of cell-free DNA (cfDNA) and KRAS-mutated ctDNA at baseline, as well as the presence of KRAS-mutated ctDNA at day 28, were strongly associated with lower disease control rates, shorter progression-free survival (PFS), and overall survival (OS). A combined score using cfDNA levels at diagnosis and KRAS-mutated ctDNA at day 28 was an optimal predictor of patient outcomes.
    • Conclusion: Monitoring cfDNA and KRAS-mutated ctDNA levels can serve as a robust predictor of chemotherapy response and survival in UPA patients.

  2. “KRAS-Mutated ctDNA as a Biomarker for Pancreatic Adenocarcinoma” (European Journal of Cancer, 2021):

    • Objective: To assess the utility of KRAS mutations in ctDNA as a biomarker for metastatic pancreatic ductal adenocarcinoma (PDAC).
    • Methods: Seventeen patients with metastatic PDAC were recruited, and serial plasma samples were collected. ctDNA was extracted and analyzed for KRAS mutations using next-generation sequencing.
    • Findings: KRAS mutations were detected in 29.4% of patients. Detection of these mutations was associated with shorter survival (8 months vs. 37.5 months in mutation-negative patients). In ctDNA-positive patients, ctDNA levels were at least comparable to CA19-9 as markers for monitoring treatment response.
    • Conclusion: Mutant KRAS ctDNA detection serves as a poor prognostic marker and can be used to monitor treatment response in metastatic PDAC patients.

  3. “Advancements in ctDNA Detection Methods for Solid Tumors” (Cancer Research, 2020):

    • Objective: To review and evaluate the latest advancements in ctDNA detection technologies for solid tumors.
    • Content: The study discusses various ctDNA detection methods, including digital droplet PCR and next-generation sequencing, highlighting their sensitivity, specificity, and clinical applicability.
    • Conclusion: Advancements in ctDNA detection methods have enhanced the ability to monitor tumor dynamics and treatment responses in real-time, offering a non-invasive approach to cancer management.

  4. “Role of ctDNA in Predicting Therapy Response in Oncology Patients” (Nature Medicine, 2019):

    • Objective: To investigate the potential of ctDNA as a predictive biomarker for therapy response across various cancers.
    • Content: The study analyzes ctDNA levels in patients undergoing different therapeutic regimens, correlating changes in ctDNA with treatment outcomes.
    • Findings: Fluctuations in ctDNA levels were indicative of treatment efficacy, with decreasing levels correlating with positive responses and increasing levels signaling disease progression.
    • Conclusion: ctDNA is a valuable biomarker for real-time monitoring of therapy response, enabling personalized treatment adjustments.

  5. “Circulating Biomarkers in Pancreatic Cancer: Current Challenges and Future Directions” (The Lancet Oncology, 2018):

    • Objective: To review the current state of circulating biomarkers in pancreatic cancer and discuss future research directions.
    • Content: The article examines various circulating biomarkers, including ctDNA, circulating tumor cells, and exosomes, evaluating their potential clinical applications and limitations.
    • Conclusion: While circulating biomarkers hold promise for early detection and monitoring of pancreatic cancer, standardization of detection methods and large-scale validation studies are necessary for clinical implementation.

Conclusion

Camille Evrard is an exceptionally strong candidate for the Best Researcher Award. Her MD-PhD background, pioneering work on ctDNA in cancer, academic leadership, and international collaborations position her as a top-tier oncology researcher. Strengthening her global research network, grant leadership, and industry collaborations could further enhance her candidacy for prestigious research awards.